Introduction {#sec1}
============

In colorectal surgery, constructing a perfect bowel anastomosis is one of the key moments of the surgical procedure. Healing complications -- anastomotic leak -- are among the most feared complications, which increase morbidity and mortality, worsen the prognosis of the patient and negatively affect his quality of life. Despite extensive research regarding the healing of the bowel anastomosis, attempts at identifying risk factors, implementation of modern surgical techniques and improving perioperative care, the incidence of this serious complication remains high. In the literature, anastomotic leak frequency ranges widely from 0.5% to 30% \[[@cit0001]--[@cit0005]\]. The frequency of its occurrence increases aborally with the highest values in the area of the distal rectum \[[@cit0004]--[@cit0006]\].

Although the etiology of anastomotic leak in colorectal surgery is multifactorial, the vitality of the anastomosed segments of the bowel due to adequate perfusion represents one of the determining factors. However, the reliability of subjective evaluation of tissue vitality by the operating surgeon is limited \[[@cit0007]--[@cit0009]\]. Fluorescence angiography (FA) using indocyanine green (ICG) allows intraoperative visualization of the vascular network in real time and enables more objective evaluation of tissue perfusion.

Aim {#sec2}
===

The aim of our study was to evaluate the effectiveness of intraoperative fluorescence angiography using ICG in the near infrared spectrum (NIR) as a tool for decreasing the anastomotic leak rate (ALR) after laparoscopic or robotic rectal resection with total mesorectal excision for cancer.

Material and methods {#sec3}
====================

The study comprised 50 sequentially included patients aged over 18 years of age, who underwent elective low rectal resection for cancer with total mesorectal excision, with primary double stapling end-to-end anastomosis and protective ileostomy by laparoscopic or robotic technique between August 2015 and February 2017. Intraoperative fluorescence angiography using indocyanine green in the near infrared spectrum was performed in these patients with the aim to objectively evaluate perfusion of the resection line. Patients with rectal cancer recurrence, those acutely operated or those with converted minimally invasive operations, as well as patients with a known allergy to iodine substances and pregnant or breastfeeding patients were excluded from the study. The results were compared with a control group of 50 electively operated patients, who underwent the identical non-converted minimally invasive procedure in the past without the use of fluorescence angiography. Patients from both groups were operated on by the same surgeons from the colorectal team. The study was a prospective, unicentric, non-randomized comparative study approved by the Institutional Ethics Committee.

Demographic and clinical patient data (gender, age, body mass index, ASA classification, comorbidities, nutrition status, medication with corticosteroids or smoking), data regarding the diagnosis of rectal cancer (TNM classification -- 8^th^ edition, neoadjuvant radio/chemotherapy, distance of the cancer from the anal verge), characteristics of the surgical procedure (surgical technique, operation duration, blood loss, intraoperative complications), parameters of intraoperative fluorescence angiography (time necessary to achieve visualization, overall examination time, correction of the resection line based on visualized perfusion, side effects of ICG) and data regarding postoperative course (morbidity, mortality, anastomotic leak, postoperative complications according to the Clavien-Dindo classification, duration of hospital stay, resection of protective ileostomy) were studied prospectively.

To evaluate the perfusion of the resection line following mobilization and dissection of the bowel, indocyanine green (ICG-Pulsion 5 mg/ml Pulsion Medical Systems, Munich, Germany) was applied intravenously in a dose of 0.2 mg/kg. Visualization of the vascular system was provided by the laparoscopic SPIES system (KARL STORZ GmbH & Co. KG, Tuttlingen, Germany) or the Firefly robotic surgical system da Vinci Xi (Intuitive Surgical, Sunnyvale, CA, USA). Evaluation of perfusion of the determined resection line was performed individually by the surgeon, who then decided on the extent of correction of the resection line, if necessary. The colorectal anastomosis was examined in all patients using contrast examination (low irrigography) performed within 30 days of surgery. Anastomotic leak was classified according to the International Study Group of Rectal Cancer \[[@cit0010]\].

The primary aim of the comparative study was to evaluate the effectiveness of fluorescence angiography using ICG in decreasing the incidence of anastomotic leak of the colorectal anastomosis. Secondary aims were to evaluate the feasibility, safety and sensitivity of intraoperative fluorescence angiography using ICG in the NIR spectrum.

Statistical analysis {#sec3.1}
--------------------

Descriptive statistical methods (mean, standard deviation, median, range and relative frequency) were used for data interpretation and statistical analysis. Student's *t*-test and the Mann-Whitney *U* test were used for statistical comparison when the dependent variable was continuous, and the χ^2^ test in the case of categorical variables. A *p*-value less than 0.05 was considered to be statistically significant.

Results {#sec4}
=======

Basic demographic and clinical data of the compared sets of patients, including characteristics describing the cancer, are shown in [Tables I](#t0001){ref-type="table"} and [II](#t0002){ref-type="table"}.

###### 

Demographic and clinical patient data

  Parameter                              With fluorescence angiography (*n* = 50)   Without fluorescence angiography (*n* = 50)   *P*-value
  -------------------------------------- ------------------------------------------ --------------------------------------------- -----------
  Age \[years\]:                                                                                                                  0.161
   Mean ± SD                             62.4 ±9.0                                  65.0 ±9.4                                     
   Median (range)                        64.0 (44--78)                              66.5 (35--81)                                 
  Gender (male/female), *n* (%)          34 (68)/16 (32)                            29 (58)/21 (42)                               0.300
  BMI \[kg/m^2^\]:                                                                                                                0.517
   Mean ± SD                             27 ±4                                      27 ±5                                         
   Median (range)                        26 (20--38)                                27 (17--41)                                   
  ASA (I/II/III/IV), *n* (%)             0 (0)/36 (72)/14 (28)/0 (0)                0 (0)/31 (62)/17 (34)/2 (4)                   0.447
  Diabetes, *n* (%)                      8 (16)                                     10 (20)                                       0.603
  Corticosteroids, *n* (%)               2 (4)                                      4 (8)                                         0.340
  Hypertension, *n* (%)                  22 (44)                                    32 (64)                                       0.045
  Atherosclerosis, *n* (%)               8 (16)                                     4 (8)                                         0.218
  Coagulopathy, *n* (%)                  0 (0)                                      4 (8)                                         0.041
  Smoker/ex-smoker/non-smoker, *n* (%)   14 (28)/5 (10)/31 (62)                     5 (10)/7 (14)/38 (76)                         0.070

###### 

Characteristics of the tumor

  Parameter                                  With fluorescence angiography (*n* = 50)   Without fluorescence angiography (*n* = 50)   *P*-value
  ------------------------------------------ ------------------------------------------ --------------------------------------------- -----------
  TNM (0/I/II/III/IV), *n* (%)               9 (18)/21 (42)/9 (18)/8 (16)/3 (6)         10 (20)/13 (26)/11 (22)/ 15 (30)/1 (2)        0.261
  Preoperative radio/chemotherapy, *n* (%)   34 (68)                                    37 (74)                                       0.509
  Distance from anal verge \[mm\]:                                                      0.417                                         
   Mean ± SD                                 46 ±13                                     46 ±15                                        
   Median (range)                            47 (20--80)                                47 (10--90)                                   

There was a significantly greater representation of patients with hypertension and coagulopathy in the control group. There was no significant difference in nutrition status, location or stage of the cancer between the two groups. The rate of patients who underwent preoperative neoadjuvant therapy was also similar.

Characteristics of the surgical procedures are presented in [Table III](#t0003){ref-type="table"}.

###### 

Operation data

  Parameter                                          With fluorescence angiography (*n* = 50)   Without fluorescence angiography (*n* = 50)   *P*-value
  -------------------------------------------------- ------------------------------------------ --------------------------------------------- -----------
  Operation technique (laparoscop./robot), *n* (%)   35 (70)/15 (30)                            37 (74)/13 (26)                               0.656
  Operation time \[min\]:                                                                                                                     0.018
   Mean ± SD                                         242 ±48                                    219 ±45                                       
   Median (range)                                    240 (158--410)                             210 (130--365)                                
  Duration of FA \[min\]:                                                                                                                     --
   Mean ± SD                                         6 ±4                                       --                                            
   Median (range)                                    5 (3--20)                                                                                
  Blood loss \[ml\]:                                                                                                                          0.441
   Mean ± SD                                         52 ±47                                     51 ±64                                        
   Median (range)                                    30 (5--200)                                30 (300)                                      
  Blood transfusion, *n* (%)                         0 (0)                                      2 (4)                                         0.153

FA -- fluorescence angiography.

The two groups did not differ in the rate of laparoscopic and robotic procedures and were also comparable in most other studied surgical parameters, except for operation duration, which was significantly longer in the group with intraoperative FA. Fluorescence angiography in the near infrared spectrum extended the operating time by 6 min on average. Valid visualization was successfully achieved in all patients and we did not observe any side effects associated with intraoperative administration of indocyanine green.

In 6 (12%) patients, intraoperative fluorescence angiography showed worsened perfusion and the surgeon decided to move the resection line 2--5 cm orally. Repeated examination of tissue vitality was subsequently performed in 5 patients and showed good perfusion of the oral bowel for anastomosis construction.

Data regarding the postoperative course, including complications, their severity and the frequency of anastomotic leak, are presented in [Table IV](#t0004){ref-type="table"}.

###### 

Postoperative course

  Variable                                With fluorescence angiography (*n* = 50)   Without fluorescence angiography (*n* = 50)   *P*-value
  --------------------------------------- ------------------------------------------ --------------------------------------------- -----------
  Postoperative complications, *n* (%):   15 (30)                                    18 (36)                                       0.580
   Clavien-Dindo I--II                    7                                          11                                            
   Clavien-Dindo III--IV                  8                                          7                                             
  Anastomotic leak, *n* (%):              5 (10)                                     9 (18)                                        0.163
   Grade A                                2                                          8                                             
   Grade B                                2                                          1                                             
   Grade C                                1                                          0                                             
  Mortality, *n* (%)                      0 (0)                                      0 (0)                                         1.000
  Duration of hospital stay \[days\]:                                                0.013                                         
   Mean ± SD                              8 ±4                                       9 ±9                                          
   Median (range)                         7 (5--24)                                  6 (4--50)                                     

The incidence and severity of postoperative complications did not differ between the two groups. In the group with fluorescence angiography, the frequency of the incidence of anastomotic leak decreased by 8% (18% vs. 10%) and the duration of hospital stay was significantly shorter. Protective ileostomy was reversed in all patients in both groups.

Discussion {#sec5}
==========

Despite significant advances of colorectal surgery in the past years, there has not been a radical decrease in the incidence of anastomotic leaks. In a meta-analysis and systematic review of 98 prospective studies in rectal surgery, the authors Paun *et al.* report that there is no significant difference in the frequency of leaks reported in publications before and after 2003 \[[@cit0011]\]. Therefore, much attention remains focused on the issue of bowel anastomosis healing.

The key requirements for uncomplicated healing are mechanical integrity and tissue vitality. Although intraoperative mechanical control of the integrity of the anastomosis has been standardly performed for a long time, objective evaluation of tissue vitality has only recently been introduced into clinical practice. In current colorectal surgery, a very promising method in this regard seems to be intraoperative fluorescence angiography using indocyanine green in the spectrum of near infrared light, which enables evaluation of tissue perfusion and vitality in real time. To date, published works focusing on this issue remain a heterogeneous assortment of open, laparoscopic and robotic procedures with different methodology. Most are prospective case series, while comparative case-control studies are rarely represented \[[@cit0009], [@cit0012]--[@cit0016]\]. Our work reports the results of comparing a relatively homogeneous set (elective low rectal resection for cancer with total mesorectal excision performed by minimally invasive technique without conversion) and with a fairly high number of patients as seen in larger studies. To date, the only similar study with a smaller number of patients was published in 2017 by Boni *et al.* \[[@cit0016]\].

Intraoperative visualization of tissue perfusion using ICG was successfully achieved in all patients in accordance with experiences reported in the literature \[[@cit0012], [@cit0017]--[@cit0021]\]. Technical execution slightly increased the duration of the surgical procedure. The administration of the indocyanine green, including repeating the dose, was completely safe, in agreement with other works \[[@cit0012], [@cit0017], [@cit0019], [@cit0021]--[@cit0025]\]. Based on our experience we consider intraoperative fluorescence angiography to be a feasible and safe method.

The effectiveness of the method is reflected in the frequency of modifications or changes to the original surgical procedure based on the performed fluorescence angiography. In our study, changes to the originally planned procedure after performing fluorescence angiography were made in 6 (12%) patients. Similarly to other studies, the changes consisted in correcting the resection lines. The available literature reports corrections in resection lines ranging from 3.7% to 40% \[[@cit0012], [@cit0017], [@cit0020], [@cit0022], [@cit0025]--[@cit0027]\]. Boni *et al.* report the relative frequency of changing the resection lines to be 4.7% in a very similar patient set \[[@cit0016]\]. In a recent systematic review, Blanco-Colino *et al.* report a correction of the planned resection line in 7.4% in a set of 555 patients with intraoperative fluorescence angiography using ICG during colorectal surgery \[[@cit0005]\].

The primary aim of the study was to evaluate the effectiveness of this method as a tool for decreasing the incidence of anastomotic leak after laparoscopic or robotic rectal resection with total mesorectal excision for cancer. In our patient set, we achieved an 8% decrease in the incidence of anastomotic leak (18% vs. 10%), although this result was not statistically significant, probably due to the small patient set (type II error). Similar comparative case control studies report a 4--12% decrease in the incidence of leak \[[@cit0012]\]. Boni *et al.* in the above-cited work did not observe any leak in the group of patients with intraoperative fluorescence angiography \[[@cit0016]\]. Analogous results, meaning without the presence of anastomotic leak, although in small and heterogeneous patient sets, were published by authors such as Sherwinter *et al.* \[[@cit0023]\], Ris *et al.* \[[@cit0019]\] or Martinek *et al*. \[[@cit0028]\]. The above-mentioned systematic review and meta-analysis by Blanco-Colino *et al.* indicate the positive potential of fluorescence angiography in reducing anastomotic leak in cancers of the colon and rectum \[[@cit0005]\]. Although the decrease in incidence of anastomotic leak after performing intraoperative FA was not statistically significant, it was reflected in a significantly shorter hospital stay.

Our results are limited mainly by the size of the patient set, the method (non-randomized study), and subjective evaluation of the perfusion image on the monitor. Despite all efforts, quantitative analysis of the fluorescence image is currently not generally available. Software analysis of the image, evaluation of the intensity of the fluorescence \[[@cit0029]\] or speed of its onset \[[@cit0030]\] requires standardized conditions which are difficult to achieve during regular operation. It may, however, be another step towards decreasing the incidence of this feared complication. Nonetheless, other questions remain. Should the perfusion test be performed only on the resection margins or also on the completed anastomosis? Can transanal examination of the low colorectal/coloanal anastomosis be useful? Another issue to consider is early follow-up using imaging methods to evaluate tissue vitality and monitoring levels of biomarkers \[[@cit0031]\], when there is suspicion of healing complications of the low anastomosis. A solution to at least some of these problems is studies with high quality methodology (not necessarily randomized studies) with a sufficient number of patients.

Conclusions {#sec6}
===========

Fluorescence angiography using indocyanine green in the near infrared spectrum is a safe, easily performed, non-time-consuming and safe examination which allows intraoperative visualization of perfusion of the resection line and, based on our experience, contributes to a significant reduction of anastomotic leak after laparoscopic or robotic rectal resection with total mesorectal excision for cancer.
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